---
title: "Broadwood Partners Plans to Vote Against Staar Sale to Alcon"
description: "Broadwood Partners, holding 27.3% of Staar Surgical, plans to vote against the company's sale to Alcon, citing concerns over the sale process and Staar's growth potential. They argue that Staar did no"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/255683836.md"
published_at: "2025-09-02T23:20:29.000Z"
---

# Broadwood Partners Plans to Vote Against Staar Sale to Alcon

> Broadwood Partners, holding 27.3% of Staar Surgical, plans to vote against the company's sale to Alcon, citing concerns over the sale process and Staar's growth potential. They argue that Staar did not adequately pursue the sale and faced issues regarding access to records. Staar defends the deal, highlighting a 51% premium to its recent closing price and asserting that the $28-per-share offer exceeds potential standalone value, despite challenges in the market, particularly in China.

By Josh Beckerman

Broadwood Partners, which owns 27.3% of Staar Surgical, said it intends to vote against the lens company's sale to Alcon, citing issues related to the sale process and its belief in Staar's growth potential.

Broadwood said Tuesday that Staar didn't pursue an adequate sale process and there was "intransigence with respect to the process regarding Broadwood's books and records demand."

Staar said the deal provides "compelling, premium cash value," including a 51% premium to its Aug. 4 closing price.

"We believe the $28-per-share cash value provided by the Alcon agreement exceeds what STAAR could achieve on a standalone basis in the foreseeable future, particularly given STAAR's lower growth rate and the resulting impact on its valuation, and the substantial competitive and macro challenges in the markets STAAR serves," the company said.

"STAAR is heavily exposed to China, which faces significant economic uncertainty and where sales trends have been declining despite actions taken by the company," Staar said. The Alcon deal includes provisions that are highly favorable to Staar stockholders and were extensively negotiated, it said.

Write to Josh Beckerman at josh.beckerman@wsj.com

(END) Dow Jones Newswires

September 02, 2025 19:07 ET (23:07 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

### Related Stocks

- [ALC.US - Alcon](https://longbridge.com/en/quote/ALC.US.md)
- [STAA.US - STAAR Surgical](https://longbridge.com/en/quote/STAA.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 瑞士的愛爾康公司完成了價值 6.02 億瑞士法郎的股票回購 | 瑞士愛爾康完成 6.02 億瑞士法郎的股票回購 | [Link](https://longbridge.com/en/news/273173070.md) |
| 愛爾康取消了對美國 STAAR Surgical 的收購計劃 | 愛爾康放棄對美國達視光學的收購計劃 | [Link](https://longbridge.com/en/news/271736841.md) |
| 消息來源稱，Guynn 的任命仍需美聯儲董事會投票 | Guynn 的任命仍需聯邦儲備委員會投票通過 - 消息來源 | [Link](https://longbridge.com/en/news/275914646.md) |
| 經濟簡報：投票可能會在今天儘早進行 | 經濟簡報：投票可能在今天早些時候進行 | [Link](https://longbridge.com/en/news/275599860.md) |
| 民主黨阻止撥款法案通過 美國土安全部面臨停擺 | 美國參議院民主黨人投票阻止一項為國土安全部提供資金的撥款法案，導致該部門面臨停擺。投票結果為 52 票贊成、47 票反對，未能達到推進法案所需的 60 票。停擺將影響多個關鍵機構，包括聯邦緊急事務管理局和運輸安全管理局。參議院共和黨計劃提出 | [Link](https://longbridge.com/en/news/275824701.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.